Form 4: Aspen Aerogels Director, James E. Sweetnam, Reports Acquisition of Stock Options and Restricted Stock Units

Director James E. Sweetnam reports acquisition of stock options and restricted stock units (RSUs) as part of annual equity grant for non-employee directors.

Summary

• On April 30, 2025, James E. Sweetnam, a director of Aspen Aerogels, Inc. (ASPN), reported acquiring 10,370 Restricted Stock Units (RSUs) and 9,105 stock options.
• The RSUs and stock options were granted as part of the annual equity grant for service as a non-employee director, according to the Issuer's Non-Employee Director Compensation Policy.
• Each RSU represents the right to receive one share of Aspen Aerogels common stock upon vesting.
• The RSUs and options will vest on the earlier of April 30, 2026, or the day prior to the Issuer's annual meeting of stockholders in 2026.
• Sweetnam directly owns 25,951 shares of Common Stock, including the 10,370 RSUs.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant, which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The equity grants align director compensation with company performance and shareholder value.
• The vesting schedule encourages continued service by the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the equity grants.

Industry Context

This filing is a routine disclosure of insider transactions, common for publicly traded companies. It reflects standard practices for compensating non-employee directors with equity.

Comparison to Industry Standards

• Equity compensation for non-employee directors is a common practice among publicly traded companies to align their interests with those of shareholders.
• The vesting schedule of one year is fairly standard.
• The specific amount of equity granted would need to be compared to peer companies of similar size and industry to determine if it is within the typical range.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align director interests with company performance.
• Employees may see this as a standard part of the company's compensation practices.

Key Dates

Keywords

Aspen Aerogels, Director Compensation, Form 4, Equity Grant, RSUs, Stock Options, Insider Trading